Summary
340B compliance can feel complicated, but it becomes more manageable with structure. When roles are clear, documentation is organized, and monitoring is consistent, covered entities are better positioned to protect the program and continue supporting patient care.
Covered entities participating in the 340B Drug Pricing Program carry an important responsibility. The program can help stretch resources and support care for underserved patients, but participation includes careful 340b compliance requirements. Every covered entity must understand the requirements that protect program integrity.
While each organization’s operations may look different, several core requirements should be consistently monitored.
Maintain eligibility
A covered entity must continue to meet eligibility and 340B compliance requirements to purchase covered outpatient drugs at 340B prices. Eligibility is not something to review only at enrollment. Changes in grant status, hospital classification, disproportionate share percentage, outpatient locations, service lines, or provider arrangements and contracts may affect program requirements and the entity’s ongoing eligibility. These items need to be at the forefront of 340B compliance and any changes must be reported to the Office of Pharmacy Affairs immediately.
Annual recertification is also important. Covered entities should keep OPAIS records accurate and maintain documentation that supports their eligibility. Each covered entity is subject to an annual recertification during the calendar year and must provide any and all applicable eligibility documentation at that time.
Prevent diversion
Diversion occurs when a 340B drug is provided to an individual who is not an eligible patient of the covered entity. Preventing diversion requires clear patient definition policies, reliable encounter documentation, accurate provider records, and careful claims review.
This can become more complicated when an organization has multiple locations, referral relationships, contract pharmacies, or specialty services. A covered entity should be able to demonstrate why each 340B claim is connected to an eligible patient under care of the covered entity for the appropriate applicable services.
Prevent duplicate discounts
The 340B statute prohibits duplicate discounts. In practical terms, this means a manufacturer should not be required to provide both a 340B discount and a Medicaid drug rebate on the same drug. Covered entities need mechanisms to prevent this risk.
Covered entities are required to review and maintain their information contained in the Medicaid Exclusion File when applicable. They must also coordinate with state Medicaid programs, reviewing Medicaid managed care processes, and ensuring that internal systems match documented policy.
Maintain auditable records
Good documentation is one of the strongest compliance tools a covered entity can have. Records should support eligibility, patient status, provider relationships, purchasing, dispensing, Medicaid billing, pharmacy service agreements, policy and procedures, and any corrective action plans.
Documentation should also be accessible. During an audit or review, the organization may need to respond quickly to data requests. A program that depends on one person’s memory or informal files is more vulnerable than one with organized records and shared accountability.
Oversee contract pharmacies and vendors
Using a contract pharmacy or third-party administrator does not transfer 340B compliance requirements and responsibility away from the covered entity. Contracts, claims files, system logic, replenishment activity, and pharmacy performance should be reviewed regularly. Any issues or non compliance or potential concerns should be addressed and reviewed by multi disciplinary team members in a timely manner.
Covered entities should also understand how manufacturer restrictions, claims submission requests, and pharmacy network changes affect program operations. These issues can influence both compliance and financial performance.
Monitor continuously
A healthy 340B compliance program includes recurring self-audits, policy updates, staff education, leadership review, and corrective action follow-up. Compliance should be part of a regular operating rhythm, not a rushed project before an audit.
Ravin Consultants helps covered entities build this rhythm. Our team supports compliance audits, mock audits, policy and procedure review, claims testing, provider review, contract pharmacy oversight, and ongoing program education.
Turn 340B compliance requirements into confidence
Meeting 340B compliance requirements can feel complicated, but it becomes more manageable with structure. When roles are clear, documentation is organized, and monitoring is consistent, covered entities are better positioned to protect the program and continue supporting patient care.
To strengthen your compliance foundation or prepare for a review, connect with Ravin Consultants today.